Article
Infectious Diseases
Vannesa Yue May Teng, Yan Ting Chua, Eunice En Ni Lai, Shilpa Mukherjee, Jessica Michaels, Chen Seong Wong, Liang Shen, Yee Sin Leo, Barnaby Young, Sophia Archuleta, Catherine W. M. Ong
Summary: The study found that screening for latent TB infection is low among HIV-TB co-infected patients in Singapore, and initiation of ART treatment may be delayed for some patients. It was also noted that pulmonary TB patients with HIV can still be infectious despite showing a normal chest x-ray.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Immunology
Yang Tang, Yanhua Yu, Quan Wang, Zilu Wen, Ruixue Song, Yu Li, Yingquan Zhou, Ruiying Ma, Hongyan Jia, Shaoli Bai, Harimulati Abdulsalam, Boping Du, Qi Sun, Aiying Xing, Liping Pan, Jianyun Wang, Yanzheng Song
Summary: HIV-infected individuals are at high risk of developing active tuberculosis (TB) and the performance of interferon-gamma release assays (IGRAs) in this population is suboptimal. Interferon-inducible protein 10 (IP-10) mRNA may serve as a better biomarker for diagnosing TB in HIV-infected individuals.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2023)
Review
Biochemistry & Molecular Biology
Chandre Liebenberg, Laneke Luies, Aurelia A. Williams
Summary: The HIV/AIDS and TB pandemics are perpetuated by a substantial global burden of HIV/TB co-infection, with immunological deterioration and metabolic mechanisms playing important roles in their synergy during co-infection. Metabolomics as a tool for studying HIV/TB co-infection offers insights into infection- and treatment-induced metabolic adaptations, but further research is needed to fully understand this complex interaction.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Article
Automation & Control Systems
Zhong-Kai Guo, Hai-Feng Huo, Hong Xiang
Summary: This paper studies the co-infection model of human immunodeficiency virus and tuberculosis and proposes optimal control strategies to help achieve the goal of ending tuberculosis. The study also finds that the availability of funds is crucial for tuberculosis control.
JOURNAL OF THE FRANKLIN INSTITUTE-ENGINEERING AND APPLIED MATHEMATICS
(2022)
Article
Engineering, Mechanical
A. Tanvi, Rajiv Aggarwal, Yashi A. Raj
Summary: In this article, a novel fractional order model is introduced for HIV-TB co-infection to incorporate the memory effect of both diseases. The analysis of both HIV and TB sub-models shows the stability of disease-free equilibrium points and the existence of endemic equilibrium points. Numerical simulations confirm the role of fractional order in co-infection modeling. Memory effect plays a significant role in reducing infection prevalence and increasing the number of recovered individuals when introduced in the fractional order model.
NONLINEAR DYNAMICS
(2021)
Article
Multidisciplinary Sciences
Sylvia M. LaCourse, Evans Seko, Rachel Wood, Wilfred Bundi, Gregory S. Ouma, Janet Agaya, Barbra A. Richardson, Grace John-Stewart, Steve Wandiga, Gerard A. Cangelosi
Summary: In this study conducted in Kenya, the diagnostic performance of oral swab analysis (OSA) for tuberculosis (TB) was evaluated. The results showed that the sensitivity of buccal swabs varied depending on the reference standard used, with a sensitivity of 65.0% for sputum Xpert/culture and 76.5% for sputum Xpert alone. The sensitivity of buccal swabs was higher among HIV-infected individuals, but further optimization and evaluation of its utility in different settings are needed.
Article
Immunology
Yuting Tan, Wei Guo, Qi Zhu, Shihui Song, Yanni Xiang, Songjie Wu, Shi Zou, Yajun Yan, Ling Feng, Mingqi Luo, Ling Shen, Yong Feng, Ke Liang
Summary: This study investigated the function of peripheral cytokine-secreting cells in HIV/TB co-infection. The results showed that the absolute numbers of these cells were lower in patients with HIV/TB co-infection compared to TB or HIV infection alone. Additionally, the functional profiles of these cells were significantly different in HIV/TB co-infection. Furthermore, measuring the percentage of cytokine-secreting cells may be a sensitive marker for early evaluation of anti-TB treatment efficacy in HIV/TB co-infection.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2023)
Article
Infectious Diseases
Chandre Herbert, Laneke Luies, Du Toit Loots, Aurelia A. Williams
Summary: The synergy between HIV and tuberculosis during co-infection leads to immunological deterioration and metabolic disruptions in the host. This study found that HIV/TB co-infection significantly affects the host's lipid and protein metabolism, as well as the translocation of microbial products from the gut to the blood. Antiretroviral therapy partially reverses these metabolic changes.
BMC INFECTIOUS DISEASES
(2023)
Article
Multidisciplinary Sciences
Zirwatul Adilah Aziz, Noorliza Mohamad Noordin, Wan Mazlina Wan Mohd, Mohd Amin Kasim
Summary: Diagnosis and treatment of tuberculosis infection (TBI) are crucial for tuberculosis elimination. A new digital lateral flow assay, QIAreach QuantiFERON-TB (QIAreach QFT), showed high agreement with QuantiFERON-TB Gold Plus (QFT-Plus) assay in terms of sensitivity, specificity, and overall agreement. QIAreach QFT could serve as an accurate and reliable point-of-need test for TB infection diagnosis, especially in decentralized settings with limited laboratory expertise and infrastructure.
Article
Virology
Marina Nosik, Maria G. Belikova, Konstantin Ryzhov, Darya Avdoshina, Alexandr Sobkin, Vitaly Zverev, Oxana Svitich
Summary: HIV-1/TB coinfection leads to imbalanced production of proinflammatory cytokines, suppressing antimicrobial immune response and leading to disease severity and prognosis. Certain cytokine levels are closely associated with disease severity and mortality in these patients.
Article
Infectious Diseases
Esther Uwimaana, Bernard S. Bagaya, Barbara Castelnuovo, David P. Kateete, Anguzu Godwin, Noah Kiwanuka, Christopher C. Whalen, Moses L. Joloba
Summary: The study investigated the potential role of HO-1 and neopterin in TB diagnosis. While there were differences in concentrations of HO-1 and neopterin among active TB patients and latently infected individuals, both biomarkers showed poor ability to distinguish between active TB and latent TB.
BMC INFECTIOUS DISEASES
(2021)
Article
Multidisciplinary Sciences
Patricia Comella-del-Barrio, Jose Luis Izquierdo-Garcia, Jacqueline Gautier, Mariette Jean Coute Doresca, Ramon Campos-Olivas, Clara M. Santiveri, Beatriz Muriel-Moreno, Cristina Prat-Aymerich, Rosa Abellana, Tomas M. Perez-Porcuna, Luis E. Cuevas, Jesus Ruiz-Cabello, Jose Dominguez
Summary: In this study, differences in metabolic response in children with different diagnostic certainty of TB were identified using urine nuclear magnetic resonance-based metabolomics. This could help improve the accuracy of TB diagnosis and prediction in pediatric populations.
SCIENTIFIC REPORTS
(2021)
Article
Biochemistry & Molecular Biology
Daniel Adon Mapamba, Elingarami Sauli, Julieth Lalashowi, Joram Buza, Joseph John, Zawadi Mwaisango, Peter Tarmo, Issa Sabi, Andrea Rachow, Nyanda Elias Ntinginya, Bariki Mtafya
Summary: This study evaluated the utility of Tuberculosis Molecular Bacterial Load Assay (TB-MBLA) and lipoarabinomannan (LAM) in detecting M. tb in HIV co-infections. The results showed that the positivity rates of TB-MBLA and urine LAM were 4.8% and 14.3%, respectively, while culture and microscopy of sputum counterparts had positivity rates of 20.6% and 12.7%, respectively. The study found that TB-MBLA has the potential to improve the detection of M. tb in urine of HIV co-infected patients.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Pharmacology & Pharmacy
Eleni Aklillu, Alimuddin Zumla, Abiy Habtewold, Wondwossen Amogne, Eyasu Makonnen, Getnet Yimer, Juergen Burhenne, Ulf Diczfalusy
Summary: This study evaluated the impact of efavirenz/rifampicin co-treatment and time of ART initiation on CYP3A induction in TB-HIV co-infected patients. Rifampicin induced CYP3A more potently than efavirenz, with maximum induction occurring within the first 4 weeks of rifampicin therapy. The time of ART initiation during anti-TB therapy did not significantly affect CYP3A induction.
BRITISH JOURNAL OF PHARMACOLOGY
(2021)
Article
Multidisciplinary Sciences
Mesfin Esayas Lelisho, Teramaj Wongel Wotale, Seid Ali Tareke, Bizuwork Derebew Alemu, Sali Suleman Hassen, Daniel Melese Yemane, Birhanu Bedada Korsa, Namso Geda Bedaso
Summary: This study aimed to determine the survival rate and predictors of mortality among TB/HIV co-infected patients. The study found that high mortality of TB/HIV co-infected patients occurred in the earlier months of treatment initiation. Factors such as older age, urban residence, WHO clinical stage II & IV, CD4 count of >= 200 cells/mm(3), bedridden functional status, and use of specific drugs were associated with the survival time of TB and HIV co-infected patients.
SCIENTIFIC REPORTS
(2022)
Review
Immunology
G. Vithiya, P. Shunmuga Sundaram
Summary: This case describes a patient who developed infection after percutaneous transluminal coronary angioplasty and subsequently died due to improper treatment, primarily caused by endocarditis caused by M. abscessus.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY
(2024)
Article
Immunology
Pheba Stanley, Nonika Rajkumari, Monika Sivaradjy
Summary: The study aimed to detect the mutation patterns in drug targets in Plasmodium vivax that develop resistance to common antimalarial agents in India. By analyzing 27 Plasmodium vivax isolates, the study found an increase in the proportion of double mutants in pvmdr1 and pvdhfr over time. Cases with double mutant pvmdr1 gene had a prolonged hospital stay compared to those without, indicating reduced clinical response to chloroquine.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY
(2024)
Letter
Immunology
Amnuay Kleebayoon, Viroj Wiwanitkit
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY
(2024)